You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

ISRADIPINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Isradipine

A generic version of ISRADIPINE was approved as isradipine by WATSON LABS TEVA on January 5th, 2006.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ISRADIPINE?
  • What are the global sales for ISRADIPINE?
  • What is Average Wholesale Price for ISRADIPINE?
Drug patent expirations by year for ISRADIPINE
Drug Prices for ISRADIPINE

See drug prices for ISRADIPINE

Recent Clinical Trials for ISRADIPINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Menarini International Operations Luxembourg SAPhase 4
National Institute on Drug Abuse (NIDA)Early Phase 1
University of Texas at AustinEarly Phase 1

See all ISRADIPINE clinical trials

Pharmacology for ISRADIPINE
Medical Subject Heading (MeSH) Categories for ISRADIPINE

US Patents and Regulatory Information for ISRADIPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-001 Apr 24, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-002 Jan 5, 2006 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Elite Labs Inc ISRADIPINE isradipine CAPSULE;ORAL 077169-002 Apr 24, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs Teva ISRADIPINE isradipine CAPSULE;ORAL 077317-001 Jan 5, 2006 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ISRADIPINE isradipine TABLET, EXTENDED RELEASE;ORAL 201067-002 Nov 27, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience ISRADIPINE isradipine TABLET, EXTENDED RELEASE;ORAL 201067-001 Nov 27, 2015 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.